Karin Bowen

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation

Bella Kaufman, Ronnie Shapira‐Frommer, Rita K. Schmutzler et al. · Journal of Clinical Oncology · 2014 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +17

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies‐Gow, Jonathan Corren, Arnaud Bourdin et al. · New England Journal of Medicine · 2021 · 967 citations · Full text

Life Sciences, Immunology, Internal Medicine +6

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With <i>KRAS</i>-Mutant Advanced Non–Small Cell Lung Cancer

Pasi A. Jänne, Michel M. van den Heuvel, Fabrice Barlési et al. · JAMA · 2017 · 332 citations · Full text

Medicine, Oncology, Pharmacology +17

Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials

Reynold A. Panettieri, Ulf Sjöbring, AnnaMaria Péterffy et al. · The Lancet Respiratory Medicine · 2018 · 227 citations · Full text

Medicine, Immunology, Pharmacology +9

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

Jonathan Corren, Andrew Menzies‐Gow, Geoffrey Chupp et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 160 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14